Keywords: mmv, gsk, develop, antimalarial, medicines, malaria, venture

MMV and GSK to develop antimalarial

Article | 22 November 2004

Print This

Medicines for Malaria Venture and UK drug major GlaxoSmithKline have signed an agreement to develop GW844520X, a member of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in